USPTO 2015–2025 USPTO PatentsView US Corporation

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center

Q: Where does THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center ranks #30,387 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: Is THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center.

Q: How is the THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, THE ranks #30,387 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 10 technology areas.

#30,387
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 10.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30387 · US Corporation #30,387 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #30,387/49,997
PHOTO-FINISH THE Government OF…
CPC-FOCUS A61K · 10 areas
INNOV-THIN 38.7/100
CLAIMS-PAR 10.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: THE Government OF THE United States OF America AS Represent BY THE Secretary OF THE AIR Force (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Salvia BioElectronic… · near

39
Aquifi · near

39
Nationwide Children'… · near

39
Studiengesellschaft… · near

39
THE Lundquist… · this assignee

39
3D Lighting… · lowest

7

What this shows THE's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where THE's grants concentrate

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2021. By volume, THE sits between THE Government OF THE United States OF America AS Represent BY THE Secretary OF THE AIR Force and Theaprin Pharmaceuticals, Inc..

THE's three-year grant acceleration

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

THE Government OF…

9
THE JOY Factory

9
THE KUN Shoulder…

9
THE Laryngeal Mask

9
THE Monadnock

9
THE Reynolds AND…

9
THE Surgical Inte…

9
Theaprin Pharmace…

9
THE Lundquist Ins… ◀

9

What this shows THE holds 9 patents at rank #30,324, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #30,324 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in THE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for THE, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Studiengesellschaft Kohle gGmbH 39 Nationwide Children's Hospital, Inc. 39 Aquifi, Inc. 39 Salvia BioElectronics B.V. 39

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	22.2%
2021	1	11.1%
2022	2	22.2%
2024	4	44.4%

Which technologies does THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C07K - Peptides 5

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

G06F - Electric Digital Data Processing 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#30,387

of 49,997 tracked assignees

Innovation Score

38.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's patent record in context - here's where to go next.

THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #30,387 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center against THE Government OF THE United States OF America AS Represent BY THE Secretary OF THE AIR Force, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.